We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shire | LSE:SHP | London | Ordinary Share | JE00B2QKY057 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4,690.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
24/4/2018 14:03 | More like we will know by the end of the week, doesn’t have to be today, I am patient, can afford to wait. Stay patient guys, too much speculation..wait for the official announcements for the facts | ny boy | |
24/4/2018 14:02 | Shire won't accept anything until it is certain there are no other bidders. | romeike | |
24/4/2018 13:52 | The new offer was made today - looks like Shire board met over the weekend and decided to ask Takeda to go away and do a bit better. | romeike | |
24/4/2018 13:48 | At last shire looks that they are about to be taken over this should see the share price get to at least 45 by Friday | seaking1 | |
24/4/2018 13:45 | Lol all these financial journalists better be right, otherwise some traders with burnt fingers, gone up 6% on all these articles. | montyhedge | |
24/4/2018 13:40 | Well I can't see a decision today . If they're still considering the offer when this last RNS was released they're not going to make up their minds in the next 2 hours before the London market closes. | philanderer | |
24/4/2018 13:36 | That's just standard text for the type of RNS. I've been looking back over the various RNS from Shire during the AbbVie bid process and the difference is very stark. For a start the Shire releases were much longer and contained detail about why the bid wasn't good enough, platform for growth, strong pipeline, double digit returns etc etc. Absolutely none of that this time around. Maybe it is just a difference in style of the people running the communications this time. Or perhaps Shire just isn't taking all this very seriously and can't even see the point of making its case. In any case the Q1 results are going to have extra significance this time - how will this as yet unknown bid sit in the context of very poor or very good Q1 figures? Have select investors been given an advance look at these figures to get them on side one way or another? | romeike | |
24/4/2018 13:35 | Looking like the early morning leak maybe came from Takeda sources. Hence Shire replies.. "without consent of Takeda" Not happy with the pressure ? | philanderer | |
24/4/2018 13:34 | A formal bid usually has a gap up in price from the last indicative offer in order to "secure the deal" - the optimist in me is hoping for £51 but I just can't see it, £48 seems more in line with their bid approach so far. It does seem that Takeda have amenable lenders on hand and Susan Kilby did extract a nice boost to the offer from AbbVie at the very last moment. | romeike | |
24/4/2018 13:27 | romeike I agree, but the share price in my view, if board reject 3600p if accept 4400p. | montyhedge | |
24/4/2018 13:25 | Yes, they are getting Shire at best very cheap at these <50 prices, at worst they are getting Shire at no premium at all - all because of sentiment. | romeike | |
24/4/2018 13:25 | Very volatile - dropped to nearly £39, then back to £39.75 a couple of minutes later. Lots of speculation and few facts other than a new undisclosed offer received today. Scfc1 | scfc1 | |
24/4/2018 13:17 | :-) 24 April 2018 Statement re revised proposal This announcement is made without the consent of Takeda. | philanderer | |
24/4/2018 12:58 | Yep. Takeda really do sound a bit desperate to buy Shire, is it because they see a bargain price??? | scfc1 | |
24/4/2018 12:56 | Is that offer number 5? | samdb | |
24/4/2018 12:53 | Roller coaster ride coming boys, if they reject 3650p if accept 4400p thats my view. | montyhedge | |
24/4/2018 12:52 | Shire Considering Revised Proposal From Takeda By Adveith Nair (Bloomberg) -- Shire says it received a revised proposal from Takeda regarding a possible offer for the Company on April 24, is considering its position. strap yourselves in. could be a choppy ride. | brahmsnliszt | |
24/4/2018 12:49 | 'The Board announces that it has received a revised proposal from Takeda regarding a possible offer for the Company on 24 April'...so the last one was seemingly rejected. The saga goes on then, Takeda looking very disciplined in their approach, errrmmm. ATB, Scfc | scfc1 | |
24/4/2018 12:34 | or bb :-) NYBoy.....thanks, GSK, ITV, WPP, NG. | demo trader | |
24/4/2018 12:31 | These stories come out, I want to hear it from Shire itself not speculation by a financial journalist. | montyhedge | |
24/4/2018 12:26 | Shire has huge debts, largely due to baxalta and the share price just reflects that. It will grow the business but this is a long term projection. Bod know this and may not agree to sell thus creating more value for stakeholders. IMO | mbmiah | |
24/4/2018 12:23 | The market has no confidence on the bod to do the right thing and sell!! | mbmiah | |
24/4/2018 12:22 | Such is the level of hate directed by the financial media towards Shire in the last year, a lot of damage has been done and Shire hasn't really done a good job of communicating it's strengths, rather they created confusion over their strategy. | romeike | |
24/4/2018 12:09 | I don't care whether Takeda paper is logistically unattractive to Shire shareholders in the UK or US,if a bid is recommended at say 47-48 quid,given the high percentage of cash,the current discount to an agreed bid is ridiculous.Something around 44 pounds would seem much more appropriate.. | steeplejack |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions